Investing Ideas
/
Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Header cover image

Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

UPDATED Apr 30, 2024

Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.

1,956 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	PHRM PharmaTher Holdings	CA$0.27	17.8%	112.0%	CA$23.5m	n/a	PB8.8x	n/a	n/a
	TXMD TherapeuticsMD	US$1.88	0%	-49.1%	US$21.7m	n/a	PS16.7x	n/a	n/a
	HASH Simply Solventless Concentrates	CA$0.25	0%	n/a	CA$12.6m	n/a	PE12.1x	n/a	n/a
	LEGN Legend Biotech	US$43.74	-7.8%	-33.4%	US$8.0b	US$86.33	PS27.9x	E61.0%	n/a
	GERN Geron	US$3.93	12.3%	58.5%	US$2.3b	US$5.79	PS9764.9x	E62.3%	n/a
	PHRX Pharmadrug	CA$0.025	-16.7%	-64.3%	CA$2.6m	n/a	PE1.8x	n/a	n/a
	CYRX Cryoport	US$16.19	0.5%	-18.4%	US$796.0m	US$18.33	PS3.4x	E31.4%	n/a
	AVDL Avadel Pharmaceuticals	US$18.16	0.4%	n/a	US$1.6b	US$23.00	PS58.8x	E58.1%	n/a
	CMRA Comera Life Sciences Holdings	US$0.04	-2.4%	-94.5%	US$1.2m	n/a	PS1.2x	n/a	n/a
	T5O bioXXmed	€0.49	3.8%	-77.7%	€2.5m	n/a	PS121.7x	n/a	n/a
	RGC Regencell Bioscience Holdings	US$5.27	-7.5%	-80.6%	US$68.6m	n/a	PB5.7x	n/a	n/a
	MSB Mesoblast	AU$0.99	10.0%	11.2%	AU$1.1b	AU$1.10	PS98.8x	E56.8%	n/a

Page 82 of 82